99% Savings - Buy Just @1 Rs X
Glyree M 1 Tablet PR is a prescription medicine that is available as a Tablet. Diabetes are some of its major therapeutic uses. Other than this, Glyree M 1 Tablet PR has some other therapeutic uses, which have been discussed ahead.
The right dosage of Glyree M 1 Tablet PR depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Glyree M 1 Tablet PR also has some side effects, the most common being Headache, Nausea or vomiting, Dizziness. Some other side effects of Glyree M 1 Tablet PR have been listed ahead. These side effects of Glyree M 1 Tablet PR are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Glyree M 1 Tablet PR is Unknown for pregnant women and Safe for women who are breastfeeding. Further, the section on Glyree M 1 Tablet PR related warnings talks about Glyree M 1 Tablet PR's effects on the liver, heart and kidney.
Glyree M 1 Tablet PR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Kidney Disease, Liver Disease are examples of such conditions. Other contraindications of Glyree M 1 Tablet PR have been discussed in the sections ahead.
Drug interactions for Glyree M 1 Tablet PR have been reported in the medical literature. See below for a complete list.
You should also be aware that Glyree M 1 Tablet PR is not safe while driving, and is not addiction.
Glyree M 1 Tablet PR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glyree M 1 Tablet PR safe for pregnant women?
The effects of Glyree M on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Glyree M 1 Tablet PR safe during breastfeeding?
Glyree M does not show any harmful effects in lactating women.
What is the effect of Glyree M 1 Tablet PR on the Kidneys?
Kidney can be affected by Glyree M. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glyree M 1 Tablet PR on the Liver?
The liver can be affected by Glyree M. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Glyree M only after medical advice.
What is the effect of Glyree M 1 Tablet PR on the Heart?
Glyree M is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glyree M 1 Tablet PR unless your doctor advises you to do so -
Is this Glyree M 1 Tablet PR habit forming or addictive?
Forming a habit of Glyree M 1 Tablet PR has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Glyree M 1 Tablet PR as you may feel sleepy.
Is it safe?
Yes, but take Glyree M 1 Tablet PR only as per medical advice.
Is it able to treat mental disorders?
Glyree M 1 Tablet PR is unable to treat or cure mental disorders.
Interaction between Food and Glyree M 1 Tablet PR
There isn't any research available on the side effects of taking Glyree M 1 Tablet PR with food.
Interaction between Alcohol and Glyree M 1 Tablet PR
Due to lack of research, there is no information about the side effects of taking Glyree M 1 Tablet PR with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826